Pradama Inc. is a specialty pharmaceutical company focused on the development and commercialization of products to treat bone diseases.

Pradama will initially concentrate on the development of its lead product candidate for the prevention and/or treatment of osteoporosis – an orally available small molecule able to induce bone formation.

Pradama also has a unique bone-targeting technology which will allow specific delivery of compounds to bone.

For more information, please contact:


William M. Pierce, Jr. Ph.D.
President and CEO
pierce@louisville.edu
502-852-7424
Andrew Steen
Vice President of Business Development
asteen@metacyte.biz
502-569-1020 x304
www.metacyte.biz